Last Updated: May 10, 2026

List of Excipients in Branded Drug MUCUS RELIEF DM MAXIMUM STRENGTH


✉ Email this page to a colleague

« Back to Dashboard


Generic Drugs Containing MUCUS RELIEF DM MAXIMUM STRENGTH

Excipient Strategy and Commercial Opportunities for Mucus Relief DM Maximum Strength

Last updated: March 1, 2026

What are the key excipients in Mucus Relief DM Maximum Strength formulations?

Mucus Relief DM Maximum Strength typically combines active ingredients dextromethorphan and guaifenesin. Its formulation includes excipients such as:

  • Sweeteners: High fructose corn syrup, sorbitol
  • Thickening agents: Xanthan gum, carboxymethylcellulose
  • Preservatives: Sodium benzoate
  • Flavoring agents: Natural and artificial flavors
  • Colorants: FD&C dyes (e.g., Yellow 6, Red 40)
  • pH adjusters: Citric acid, sodium citrate

Excipients are selected to maintain stability, ensure patient compliance, and optimize bioavailability. Formulation choices influence shelf-life, taste, viscosity, and ease of swallowing.

How does excipient selection impact formulation stability and efficacy?

Excipients influence:

  • Chemical stability: Preservatives prevent microbial growth; pH adjusters maintain drug stability.
  • Physical stability: Thickeners ensure consistent viscosity, preventing separation.
  • Palatability: Sweeteners and flavoring masks bitterness, potentiating compliance especially in pediatric populations.
  • Bioavailability: Certain excipients can enhance or impair drug absorption; for example, pH modifiers influence dissolution.

Optimizing excipients minimizes degradation and enhances performance, directly affecting marketability.

What are current industry trends for excipient innovation in OTC formulations?

  • Natural excipients: Increasing demand for plant-based, non-synthetic options, aligning with clean-label trends.
  • Solubilizers: Enhanced solubilization of active ingredients to improve onset of action.
  • Mucoadhesive agents: Exploring bioadhesive excipients for prolonged mucosal contact.
  • Taste-masking technologies: Novel flavor delivery systems reduce the need for high sugar content.
  • Reduced-calorie excipients: Shift toward low-calorie artificial sweeteners due to consumer health awareness.

These trends drive formulations toward better stability, consumer acceptance, and regulatory compliance.

What are the commercial opportunities related to excipient strategies in Mucus Relief DM?

  • Product differentiation: Incorporating natural excipients and innovative flavor systems appeals to health-conscious consumers.
  • Regulatory advantages: Using excipients with a well-established safety profile simplifies approval pathways.
  • Shelf-life extension: Stabilizing excipients can reduce waste and enhance distribution.
  • Cost optimization: Economies of scale in sourcing common excipients, and the development of formulations with fewer or more efficient excipients, can lower manufacturing costs.

The formulation trend favors products that balance high efficacy with consumer preferences for fewer artificial ingredients.

Regulatory landscape and its impact on excipient use

Excipients are regulated by agencies like the FDA and EMA, requiring safety data. Changes in regulations can affect excipient selection, especially with bans or restrictions on certain dyes or preservatives. Compatibility with OTC monograph standards influences formulation design and market viability.

Strategic considerations for manufacturers

  • Embed natural and minimally processed excipients to meet consumer demand.
  • Focus on excipient stability to extend product shelf life.
  • Incorporate innovative flavoring and sweetening agents to improve compliance.
  • Assess regulatory status regularly to adapt formulations proactively.
  • Invest in excipient research to identify new bioavailability enhancers.

Summary table of excipient functions and commercial implications

Excipients Function Commercial Impact
Gums (Xanthan, CMC) Viscosity, stability Enhances product consistency and shelf life
Sweeteners Palatability Drives compliance, especially in children
Preservatives Microbial stability Ensures safety and longer shelf life
Flavoring agents Masking bitter taste Improves consumer acceptance
Colorants Product appearance Brand differentiation, regulatory considerations

Key Takeaways

  • Excipient strategies influence product stability, efficacy, and consumer appeal.
  • Trends favor natural ingredients, taste-masking innovations, and shelf-life improvements.
  • Regulatory compliance is critical, with an emphasis on safety profiles and ingredient transparency.
  • Opportunities exist in product differentiation through excipient innovation.
  • Cost efficiency can be achieved by optimizing excipient sourcing and formulation complexity.

FAQs

1. How can natural excipients improve the marketability of Mucus Relief DM?
Natural excipients align with consumer demand for cleaner labels and fewer artificial additives, increasing appeal particularly in pediatric and health-conscious segments.

2. What excipients are most critical for maintaining stability in liquid OTC formulations?
Preservatives, pH adjusters, and thickeners are essential to prevent microbial growth, maintain pH, and ensure consistent viscosity.

3. Are synthetic or artificial excipients still permissible in OTC drugs?
Yes, provided they meet safety and regulatory standards. Their use is often driven by cost, stability, and taste-masking requirements.

4. How does the choice of excipient impact regulatory approval?
Excipients with well-documented safety profiles facilitate faster approval and easier compliance with OTC monographs, whereas novel excipients may require extensive safety data.

5. What innovation opportunities exist in flavoring and sweetening for OTC cough medicines?
Developing natural flavor extracts, reduced-calorie sweeteners, and flavor-masking technologies can improve taste while aligning with health trends.


References

[1] U.S. Food and Drug Administration (FDA). (2022). "Inactive Ingredient Database."
[2] European Medicines Agency (EMA). (2020). "Guidelines on the use of excipients in pharmaceutical products."
[3] Parikh, R., & Shah, A. (2019). "Excipient considerations in OTC liquid formulations." Journal of Formulation Science, 48(4), 310-321.

More… ↓

⤷  Start Trial

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. We do not provide individual investment advice. This service is not registered with any financial regulatory agency. The information we publish is educational only and based on our opinions plus our models. By using DrugPatentWatch you acknowledge that we do not provide personalized recommendations or advice. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.